GSA Capital Partners’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-334,694
| Closed | -$890K | – | 2133 |
|
|
2024
Q1 | $890K | Sell |
334,694
-4,292
| -1% | -$11.4K | 0.07% | 519 |
|
|
2023
Q4 | $803K | Sell |
338,986
-35,305
| -9% | -$83.6K | 0.07% | 509 |
|
|
2023
Q3 | $524K | Buy |
374,291
+133,948
| +56% | +$188K | 0.04% | 763 |
|
|
2023
Q2 | $728K | Buy |
240,343
+203,220
| +547% | +$616K | 0.07% | 504 |
|
|
2023
Q1 | $232K | Sell |
37,123
-33,051
| -47% | -$207K | 0.02% | 1178 |
|
|
2022
Q4 | $428K | Sell |
70,174
-3,103
| -4% | -$18.9K | 0.05% | 699 |
|
|
2022
Q3 | $876K | Buy |
73,277
+16,898
| +30% | +$202K | 0.12% | 217 |
|
|
2022
Q2 | $711K | Buy |
56,379
+9,204
| +20% | +$116K | 0.11% | 294 |
|
|
2022
Q1 | $531K | Buy |
+47,175
| New | +$531K | 0.07% | 484 |
|